| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/000486700226 |
| P698 | PubMed publication ID | 11129319 |
| P2093 | author name string | A Jablensky | |
| J Johnston | |||
| J Box | |||
| A Kent | |||
| R Stienstra | |||
| H Wichmann | |||
| D Rock | |||
| P T Michie | |||
| K Dedman | |||
| E Rutherford | |||
| R Castine | |||
| P2860 | cites work | The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria | Q28315201 |
| Imaging cognition II: An empirical review of 275 PET and fMRI studies | Q33180177 | ||
| The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis | Q33693510 | ||
| Anterior cingulate cortex, error detection, and the online monitoring of performance | Q34465841 | ||
| On familial factors in the attentional deficit in schizophrenia: a review and report of two new subject samples | Q35663751 | ||
| A summary of attentional findings in the New York High-Risk Project | Q35663754 | ||
| Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus | Q35956504 | ||
| The effect of family status and schizotypy on electrophysiologic measures of attention and semantic processing. | Q38446274 | ||
| Neuropsychological correlates of sustained attention in schizophrenia | Q38456799 | ||
| The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology | Q39412944 | ||
| Attentional networks | Q40388131 | ||
| Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes? | Q40470324 | ||
| Impaired attention, genetics, and the pathophysiology of schizophrenia | Q40759066 | ||
| What are the functional consequences of neurocognitive deficits in schizophrenia? | Q40976267 | ||
| Metabolic brain pattern of sustained auditory discrimination | Q41106533 | ||
| Evidence for a pseudoautosomal locus for schizophrenia. II: Replication of a non-random segregation of alleles at the DXYS14 locus | Q41128361 | ||
| Physical anhedonia, perceptual aberration, and psychosis proneness | Q41648057 | ||
| Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography | Q43919877 | ||
| P300 in first degree relatives of schizophrenics | Q44008509 | ||
| Frontal lesions and sustained attention. | Q45197527 | ||
| Poor P50 suppression among schizophrenia patients and their first-degree biological relatives | Q46171371 | ||
| Abnormal cingulate modulation of fronto-temporal connectivity in schizophrenia | Q48265072 | ||
| Architecture of connectivity within a cingulo-fronto-parietal neurocognitive network for directed attention | Q48323746 | ||
| Challenging the anterior attentional system with a continuous performance task: a functional magnetic resonance imaging approach | Q48353601 | ||
| Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses | Q48660010 | ||
| The continuous performance test, identical pairs version (CPT-IP): III. Brain functioning during performance of numbers and shapes subtasks | Q48765240 | ||
| Spatial working memory deficits in the relatives of schizophrenic patients | Q49132201 | ||
| Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls | Q50303593 | ||
| Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. | Q50796082 | ||
| A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. | Q50800943 | ||
| Eye-tracking dysfunctions in schizophrenic patients and their relatives. | Q50851065 | ||
| Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. | Q50866944 | ||
| The New York High-Risk Project: attention, anhedonia and social outcome. | Q50896522 | ||
| Attention Dysfunction in Chronic Schizophrenia | Q51238570 | ||
| Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. | Q52014101 | ||
| Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. | Q52022559 | ||
| Familial transmission of two independent saccadic abnormalities in schizophrenia. | Q52038631 | ||
| Neuropsychological functioning among non-psychotic siblings and parents of schizophrenic patients | Q52172883 | ||
| Effectiveness of attention training in schizophrenia. | Q52189824 | ||
| The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. | Q52245742 | ||
| Attentional vulnerability indicators, thought disorder, and negative symptoms. | Q52263264 | ||
| The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia | Q57403458 | ||
| Decreased frontal activation in schizophrenics during stimulation with the Continuous Performance Test - a functional magnetic resonance imaging study | Q57564787 | ||
| P921 | main subject | schizophrenia | Q41112 |
| phenotypic marker | Q122020619 | ||
| P304 | page(s) | S74-85 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Australian and New Zealand Journal of Psychiatry | Q4824838 |
| P1476 | title | Phenotypic markers as risk factors in schizophrenia: neurocognitive functions | |
| P478 | volume | 34 Suppl |
| Q37034804 | A developmental look at the attentional system in the at risk and first episode of psychosis: age related changes in attention along the psychosis spectrum |
| Q30945269 | Approaches for adolescents with an affected family member with schizophrenia |
| Q47595201 | Assessment of Cognition and Personality as Potential Endophenotypes in the Western Australian Family Study of Schizophrenia |
| Q31095554 | Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? |
| Q28256286 | Changes in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychoses |
| Q35068141 | Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies |
| Q36477417 | Clinical diagnoses in young offspring from eastern Québec multigenerational families densely affected by schizophrenia or bipolar disorder |
| Q37850311 | Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? |
| Q37945156 | Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia. |
| Q37075916 | Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia |
| Q35230182 | Impaired working speed and executive functions as frontal lobe dysfunctions in young first-degree relatives of schizophrenic patients |
| Q30488649 | Neurocognitive allied phenotypes for schizophrenia and bipolar disorder |
| Q46079262 | Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis |
| Q34482007 | Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study |
| Q49399287 | Smoking in schizophrenia: cognitive impact of nicotine and relationship to smoking motivators |
| Q35078020 | Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers |
Search more.